版本:
中国

BRIEF-Caligor Opco says will support Puma Biotechnology's expanded access program for PB272 (neratinib) in U.S.

April 12 Caligor Opco LLC:

* To support Puma Biotechnology's expanded access program for PB272 (neratinib) in United States

* Also is providing regulatory, logistical, supply chain support for Puma's Managed Access Program for neratinib outside United States Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐